Ingalipt

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT INHALIPT

Composition:

Active substances: 1 canister (30 ml) contains soluble streptocide 0.75 g; sodium sulfathiazole hexahydrate 0.75 g; thymol 0.015 g; eucalyptus oil 0.015 g; peppermint oil 0.015 g;

Excipients: ethanol 96%, sugar, glycerol, polysorbate 80, purified water, nitrogen – pressure up to 0.6 MPa.

Pharmaceutical form. Aerosol.

Main physicochemical properties: clear liquid, light yellow to dark yellow in color, with a characteristic odor of thymol and menthol.

Pharmacotherapeutic group.

Agents acting on the respiratory system. Preparations used in throat diseases. Antiseptics. ATC code R02A A20.

Pharmacological Properties.

Pharmacodynamics.

Ingalipt is a combination medication that exerts anti-inflammatory, antimicrobial, cooling, and distracting effects. It is active against gram-positive and gram-negative microorganisms.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications.

Infectious and inflammatory diseases of the ear, nose, and throat organs and mucous membranes of the oral cavity: tonsillitis, pharyngitis, laryngitis, aphthous and ulcerative stomatitis.

Contraindications.

Hypersensitivity to any component of the drug.

Interaction with other medicinal products and other types of interactions.

When Ingalip is used simultaneously with drugs that are derivatives of p-aminobenzoic acid (novocaine, anesthesin, dicaine), inactivation of the antibacterial activity of sulfonamides occurs.

Special precautions for use.

Before using the medication, it is recommended to rinse the mouth with warm boiled water. Remove necrotic deposits from affected areas of the oral cavity (ulcers, erosions) using sterile swabs.

After spraying the medication into the oral cavity, refrain from eating for 15–30 minutes.

Individuals prone to allergies and patients with diabetes mellitus should consult a physician prior to use, as the medication contains sugar.

Before use, remove the protective cap from the canister and attach the spray nozzle provided in the kit to the valve stem. Insert the free end of the spray nozzle into the oral cavity and press the valve head for 1–2 seconds while holding the canister vertically. To prevent clogging of the spray nozzle, blow through it or place it into a glass of clean water after each use. Replace the protective cap on the canister to prevent contamination.

Use during pregnancy or breastfeeding.

The medication may be used during pregnancy or breastfeeding only under medical supervision, after careful assessment of the benefit-risk ratio, and strictly adhering to the recommended dosage regimen.

Ability to affect reaction rate when driving or operating machinery.

Caution is advised for drivers and machine operators, as the medication contains ethanol. The medication may interfere with alcohol testing results.

Dosage and Administration

For topical use in adults and children aged 3 years and older, by spraying the mucous membranes of the oral cavity and nasopharynx.

Before use, attach the spray nozzle to the aerosol canister, shake the canister several times, then press the spray nozzle fully to evenly apply the medication onto the affected area.

During a single inhalation session, perform 2–3 sprays, retaining the medication in the oral cavity for 5–7 minutes. Administer spraying 3–4 times daily. The duration of treatment depends on the intensity of therapy and usually lasts 7–10 days.

Children

Do not use in children under 3 years of age.

In children, reflex bronchospasm may occur due to the presence of eucalyptus oil and peppermint oil in the formulation. Treatment of children should be carried out under medical supervision. Use in children aged 3 years and older, taking into account the possibility of developing reflex bronchospasm.

Overdose

In case of overdose, adverse effects of the drug may be intensified.

In all cases of overdose, discontinue use of the medication and rinse the oral cavity with warm boiled water.

Treatment is symptomatic.

Side effects.

Immune system side effects: allergic reactions, including itching, urticaria, skin rash, swelling at the site of contact; in individuals with increased sensitivity, angioneurotic edema (Quincke's edema) may develop.

Respiratory system side effects: difficulty breathing; reflex bronchospasm due to the presence of essential oils is possible.

Gastrointestinal side effects: nausea, vomiting.

Local effects: burning sensation in the mouth, sore throat, or sensation of a lump in the throat; hyperemia of the pharyngeal mucosa.

Other: general weakness.

If any adverse events or unusual reactions occur, consult a physician regarding further use of the medication.

Shelf life. 2 years.

Do not use the medication after the expiry date stated on the packaging.

Storage conditions.

Keep out of reach of children. Store in the original packaging at a temperature not exceeding 25 °C.

Protect from falls, impacts, and exposure to direct sunlight.

Packaging.

30 ml in an aluminum aerosol can; 1 can with spray dispenser per carton.

Availability. Over-the-counter (without prescription).

Manufacturer: JSC "Stoma", Ukraine.

Manufacturer's address:
Ukraine,
61105, Kharkiv, Newtona St., 3.